sglt2i users Search Results


sglt2i users  (TriNetX Inc)
90
TriNetX Inc sglt2i users
Associations between <t>SGLT2i</t> use and urolithiasis in different locations using conditional Cox regression models.
Sglt2i Users, supplied by TriNetX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sglt2i users/product/TriNetX Inc
Average 90 stars, based on 1 article reviews
sglt2i users - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sglt2i  (Anhui Medical University)
90
Anhui Medical University sglt2i
Studies investigating the potential antiarrhythmic effects of SGLT2is on AF incidence.
Sglt2i, supplied by Anhui Medical University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sglt2i/product/Anhui Medical University
Average 90 stars, based on 1 article reviews
sglt2i - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Associations between SGLT2i use and urolithiasis in different locations using conditional Cox regression models.

Journal: Clinical Pharmacology and Therapeutics

Article Title: Use of Sodium‐Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi‐Database and Cross‐Country Study in Patients With Type 2 Diabetes Mellitus

doi: 10.1002/cpt.3626

Figure Lengend Snippet: Associations between SGLT2i use and urolithiasis in different locations using conditional Cox regression models.

Article Snippet: Compared to SGLT2i users in TriNetX, those in the NHIRD were younger, had a higher proportion of males, and higher prevalence of hypertension, hyperlipidemia, CVD, gout, and urinary tract infections.

Techniques:

Studies investigating the potential antiarrhythmic effects of SGLT2is on AF incidence.

Journal: Journal of Clinical Medicine

Article Title: The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review

doi: 10.3390/jcm13185408

Figure Lengend Snippet: Studies investigating the potential antiarrhythmic effects of SGLT2is on AF incidence.

Article Snippet: Zhou et al., 2022 [ ] , First Affiliated Hospital of Anhui Medical University (China) , Observational Retrospective Single-center Study , Patients with HF (n = 903), including 78 participants with AF and 825 participants without AF at baseline. , EMPA DAPA CANA , N/A , SGLT2i users experienced a lower prevalence of AF (8.4% vs. 12.1%, p < 0.001) and a lower risk of developing AF (OR 0.76, 95% CI: [0.70–0.85], p < 0.001) compared to non-SGLT2i users. The effect of SGLT2is on AF episodes was consistent irrespectively of age, gender, BMI, and eGFR..

Techniques: Modification, Biomarker Discovery

Studies investigating the potential antiarrhythmic effects of SGLT2is on AF recurrence.

Journal: Journal of Clinical Medicine

Article Title: The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review

doi: 10.3390/jcm13185408

Figure Lengend Snippet: Studies investigating the potential antiarrhythmic effects of SGLT2is on AF recurrence.

Article Snippet: Zhou et al., 2022 [ ] , First Affiliated Hospital of Anhui Medical University (China) , Observational Retrospective Single-center Study , Patients with HF (n = 903), including 78 participants with AF and 825 participants without AF at baseline. , EMPA DAPA CANA , N/A , SGLT2i users experienced a lower prevalence of AF (8.4% vs. 12.1%, p < 0.001) and a lower risk of developing AF (OR 0.76, 95% CI: [0.70–0.85], p < 0.001) compared to non-SGLT2i users. The effect of SGLT2is on AF episodes was consistent irrespectively of age, gender, BMI, and eGFR..

Techniques: Control